/well H3 or H5-expressed 293T cells were attached to the plates prior to assay, and the medium was then replaced with low IgG serum assay buffer. Each well were added different bnAbs at concentration of 5, 1, 0.2 and 0.04 µg ml -1 . After one-hour, Jurkat effector cells were added for 6.0x10 4 /well to assay plates and incubated for 6 hours. The supernatants were measured luminescence using Bio-GloTM Luciferase Assay kits (Promega). Bars represent mean ± S.E.M. P value was calculated using two-way ANOVA, compared to F10 (upper panel) and CR8020 (lower panel). "*" represents p value for each comparison < 0.0001. Data represent a representative experiment from three independent experiments, and all tests were performed in triplicate.
Supplementary Figure 7
Supplementary Figure 7 Binding of the 3I14 IgG1 variants to recombinant H1, H3 and H5. Blue curves are the experimental trace obtained from biolayer interferometry experiments, and red curves are the best global fits to the data used to calculate the K d s presented in Table 2 . Supplementary Figure 11 Supplementary Figure 11 Trypsin Cleavage Inhibition Assay (full-size images). 0.4 µg recombinant H3-histidine (H3-BR07) was incubated in the presence of 2.5 µg 3I14 or Fm-6 IgG1, or in the absence of antibody in Tris-HCl buffer at pH 8.0 containing 2 µg ml -1 Trypsin at 37°C. Trypsin digestion was stopped at several time-points by boiling the sample in a 100°C water bath. Samples were run on 10% reduced SDS-PAGE and blotted using a HisProbe-HRP Abs. Uncleaved HA (HA0) is indicated on the right side. Table 1 Contact residues at H3/3I14 and H5/3I14 interfaces  3I14  HCDR3  LCDR1  LCDR2  LCDR3  Y103  Y104  F105*  D106  F109*  G31*  N32  T33  N52  S53*  D94  H3  I18  W21  D19  D19  L38  Q42  Q42  Q42  N49  K39  L38  L38  D46  I45  H5  D19  D19  D19  D19  K38  Q42  Q42  T49  N53  E39  I45  K38  K38  E39  D46  T41  I45 Contact residues defined by interatomic distances < 4 Å, except residue D94 in H3 and H5 complexes defined by distances < 5 Å and < 7 Å, respectively. The color scheme indicates contributions to the binding energy: very favorable (red); favorable (orange); neutral (blue) and unfavorable (black). *Residues indicate the somatic mutations of germline-encoded residues. Group 1 H1-CA09 0.28 (Fig 1c) . **Relative K d determined by Flow Cytometry (Fig 1b) and reference 16. Residues carrying positively charged side chain are labeled orange; while negatively charged side chain residues are labeled blue.
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